首页> 美国卫生研究院文献>Journal of Korean Medical Science >Interfractional Variation of Radiation Target and Adaptive Radiotherapy for Totally Resected Glioblastoma
【2h】

Interfractional Variation of Radiation Target and Adaptive Radiotherapy for Totally Resected Glioblastoma

机译:完全切除的胶质母细胞瘤的放射靶标度变化和适应性放射治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to evaluate the effects of volume adapted re-planning for radiotherapy (RT) after gross total resection (GTR) for glioblastoma. Nineteen patients with glioblastoma who underwent GTR and postoperative RT were analyzed. The volumes of the surgical cavity on computed tomography (CT) obtained one day after GTR (CT0), the first RT simulation CT (sim-CT1), and the second simulation CT for the boost RT plan (sim-CT2) were compared. The boost RT plan was based on the surgical cavity observed on the sim-CT2 (boost RTP2) and was compared with that based on the surgical cavity observed on the sim-CT1 (boost RTP1). The volume reduction ratios were 14.4%-51.3% (median, 29.0%) between CT0 and sim-CT1 and -7.9%-71.9% (median, 34.9%) between sim-CT1 and sim-CT2 (P < 0.001). The normal brain volumes in boost RTP1 were significantly reduced in boost RTP2, especially at high dose levels. Target volume in sim-CT2 which was not covered with the boost RTP1, developed in five cases (26.3%). The surgical cavity volume was reduced following surgery in patients with glioblastoma who underwent GTR. The application of volume-adapted re-planning during RT could decrease the irradiated volume of normal brain and prevent a target miss for boost RT.
机译:这项研究的目的是评估胶质母细胞瘤的总全切除(GTR)后适应放射治疗(RT)的体积适应性重新计划的效果。分析了19例接受GTR和术后RT的胶质母细胞瘤患者。比较了GTR(CT0)一天后获得的计算机断层摄影(CT)手术腔的体积,增强型RT计划的第一个RT模拟CT(sim-CT1)和第二个模拟CT(sim-CT2)。 Boost RT计划基于在sim-CT2上观察到的手术腔(增强型RTP2),并与基于在sim-CT1上观察到的手术腔(增强型RTP1)进行了比较。 CT0和sim-CT1之间的体积减小率为14.4%-51.3%(中位数为29.0%),sim-CT1和sim-CT2之间的体积减小率为-7.9%-71​​.9%(中位数为34.9%)(P <0.001)。加强型RTP2中的正常脑容量在加强型RTP2中显着降低,尤其是在高剂量水平下。 sim-CT2中的目标体积没有被增强RTP1覆盖,在五种情况下(26.3%)得到发展。接受GTR的胶质母细胞瘤患者手术后的手术腔体积减少。在放疗期间应用适应体积的重新计划可减少正常脑部的照射量,并防止升压放疗的目标遗漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号